Skip to content

    Twist Bioscience (TWST) stock price & financials

    View TWST earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+420.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $84.71M
    $88.71M
    $92.79M
    $96.06M
    $99.01M
    +16.9%
    $103.70M
    +16.9%
    $110.72M
    +19.3%
    $118.38M
    +23.2%
    Strengthening
    Operating Profit
    -$36.04M
    -$34.64M
    -$41.56M
    -$30.12M
    -$29.93M
    +16.9%
    -$32.90M
    +5.0%
    -$45.86M
    -10.4%
    -$36.28M
    -20.5%
    Weakening
    Net Profit
    -$34.66M
    -$31.59M
    -$39.33M
    $20.39M
    -$27.14M
    +21.7%
    -$30.51M
    +3.4%
    -$44.02M
    -11.9%
    -$35.05M
    -271.9%
    Weakening
    EPS
    $-0.53
    $-0.66
    $0.34
    $-0.50
    +5.7%
    $-0.71
    -7.6%
    $-0.56
    -264.7%
    Weakening
    Other Income
    Interest
    $29.0K
    $24.0K
    $143.0K
    Depreciation
    Profit before Tax
    -$34.75M
    -$31.50M
    -$39.15M
    $20.58M
    -$26.88M
    +22.6%
    -$30.25M
    +3.9%
    -$43.98M
    -12.3%
    -$34.74M
    -268.8%
    Weakening
    MarginsOPM
    -42.5%
    -39.0%
    -44.8%
    -31.4%
    -30.2%
    +29.0%
    -31.7%
    +18.7%
    -41.4%
    +7.5%
    -30.6%
    +2.3%
    Strengthening
    Tax
    0.3%
    -0.3%
    -0.5%
    0.9%
    -0.9%
    -439.3%
    -0.8%
    -171.0%
    -0.1%
    +77.8%
    -0.9%
    -196.8%
    Weakening
    ReturnsROIC
    2.4%
    2.2%
    2.8%
    -1.4%
    1.9%
    -21.7%
    2.1%
    -3.4%
    3.1%
    +11.9%
    2.5%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$80.76M$46.73M$93.67M$465.83M$378.69M$286.47M$226.32M$183.05M$117.44M
    Short-Term Investments
    Total Current Assets$95.67M$160.13M$334.87M$546.50M$596.48M$424.26M$346.78M$332.97M$321.30M
    Net PP&E$12.33M$20.84M$59.16M$105.70M$214.39M$203.36M$161.35M$151.66M$180.62M
    Goodwill$1.14M$1.14M$1.14M$22.43M$85.81M$85.81M$85.81M$82.19M$82.19M
    Intangibles$712.0K$508.0K$307.0K$18.26M$59.74M$54.48M$14.48M$13.43M$12.73M
    Total Assets$115.79M$186.99M$398.88M$702.10M$961.38M$776.40M$614.32M$641.86M$672.44M
    LiabilitiesTotal Current Liabilities$18.54M$30.35M$36.03M$63.05M$90.66M$73.32M$71.01M$91.41M$120.25M
    Short-Term Debt$2.50M$3.33M$3.33M$1.55M$0
    Long-Term Debt$7.22M$4.40M$1.40M
    Long-Term Leases$24.84M$53.16M$81.27M$79.17M$70.22M$61.75M$84.96M
    Total Liabilities$26.73M$34.91M$62.62M$121.28M$171.99M$152.97M$141.63M$168.90M$226.70M
    EquityCommon Stock & APIC$0$0$0$0$0$0$0$1.0K
    Retained Earnings-$210.85M-$318.52M-$458.45M-$610.55M-$828.42M-$1.03B-$1.24B-$1.32B-$1.43B
    Total Equity-$201.42M$152.08M$336.26M$580.82M$789.38M$623.43M$472.69M$472.96M$445.74M
    HighlightsNet Cash / (Debt)$71.04M$39.00M$88.93M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$66.16M-$87.94M-$142.25M-$112.24M-$124.39M-$142.47M-$64.09M-$47.63M-$53.07M
    Cash from Investing$27.31M-$104.81M-$114.65M$156.16M-$232.93M$50.61M-$3.07M-$24.76M-$45.24M
    Cash from Financing$88.82M$158.58M$303.73M$329.18M$270.53M$911.0K$6.89M$28.54M$13.80M
    SummaryCapital Expenditure-$3.69M-$14.76M-$9.87M-$27.06M-$101.86M-$27.78M-$5.08M-$28.00M-$40.05M
    Free Cash Flow-$69.85M-$102.69M-$152.12M-$139.31M-$226.24M-$170.25M-$69.17M-$75.63M-$93.12M
    FCF Margin-274.7%-188.8%-168.8%-105.3%-111.1%-69.5%-22.1%-20.1%-21.6%

    Ratios